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milliliter of peripheral venous blood and corrected for the acquisition time per frame and decay of the radioisotope. Left ventricular volumes determined with this technique are consistently smaller than those measured with contrast ventriculography, but a significant correlation exists between these 2 methods. Thus, a linear regression equation determined previously (y= 2.49x-8.94) was used to convert the scintigraphic estimates of volume into actual volume expressed in milliliters. Cardiac output was calculated from the products of HR, EDV and LVEF. This volumetric technique was verified earlier in 18 other subjects at rest and during exercise with simultaneous determination of cardiac output measured using the dye dilution method. The corresponding cardiac outputs determined by both methods showed a correlation coefficient of 0.89.
Study protocol of RNA study: Antianginal drugs were discontinued at least 24 hours before study. at rest as compared with those after the other 3 drugs (p<0.05), but it increased significantly on exercise (79.4ml/m2 to 96.4ml/m2, p<0.01).
On the other hand, EDVs after nifedipine and propranolol remained unchanged on exercise. Consequently, all 3 drugs equally showed lower EDV than that of the placebo during exercise.
Systemic vascular resistance: SVR decreased significantly after each regimen on exercise. After nifedipine, this parameter was significantly lower than those after the other drugs at rest, but no significant difference was observed between those of nifedipine and placebo during exercise. SVR after propranolol was significantly higher both at rest and during exercise than those after nifedipine and placebo.
There was no difference in SVR between ISDN and placebo.
P-V index and LVEF: The P-V index remained unchanged on exercise after placebo (5.1 units vs. 4.8 units). After ISDN and nifedipine, the P-V index increased significantly on exercise, while it remained unchanged after propranolol (4.8 units vs. 5.5 units). LVEF decreased during exercise from a normal resting level of 64.8% to 58.9% (p<0.05) after placebo. Following these 3 drugs, it remained unchanged on exercise. ISDN and nifedipine caused a higher P-V index and LVEF than the other 2, indicating that they improved left ventricular performance.
Propranolol, on the other hand, suppressed left ventricular performance by its own negative inotropic action.
Effects on electrocardiographic evidence of ischemia: The relation between the magnitude of ST segment depression and DP is illustrated in Fig.2 . Despite an unchanged peak DP, the average maximal exercise ST segment depression with ISDN and nifedipine was less than half as much as that with placebo (p<0.001).
Propranolol produced a smaller reduction in the magnitude of ST segment depression at peak effort, despite a much greater reduction in peak DP.
Comparison of hemodynamic effects by PANOVA The results of ANOVA and PANOVA are summarized in Table III . As shown in Fig.3, all 3 drugs had similar LV EF profiles, and placebo a different profile. The sizes of the response curves of LVEF for propranolol and placebo were significantly different from those for ISDN and nifedipine.
As for the size and profile of the response curve of DP, propranolol was significantly differentiated from the other drugs, while ISDN and nifedipine did not show any difference from placebo. With respect to the P-V index, propranolol was also significantly differentiated from ISDN and nifedipine, but it was similar to placebo in both size and profile. Figure 4 shows the response curves of EDV and the results of PCA. Both boundaries of nifedipine and propranolol deviated to the left, whereas the ISDN boundary remained in almost the same position as placebo, indicating that ISDN was similar to placebo but different from the other drugs in the profile of the EDV response curve. However, no difference in the size of EDV was observed among the 3 drugs which were different from placebo. Figure 5 shows the results of PCA in the response curve of m-BP/CO (SVR). ISDN and placebo were similar in boundary and occupied the center of the graph. There was also no difference between them in the size of the SVR response curve. Nifedipine was also similar to placebo in the profile and its boundary considerably overlapped the placebo region on the graph. It was, however, significantly differentiated from the other drugs in the size of the SVR. In contrast, despite a similarity to placebo in the profile, the propranolol boundary deviated to the right in comparison with nifedipine, thus showing that its effects were opposite to those of nifedipine on SVR.
DISCUSSI
The present study was designed to compare the acute effects of ISDN, nifedipine, propranolol and placebo on cardiac function during exercise-induced ischemia and to characterize their hemodynamic effects by PANOVA.
Usually, cardiac pump function during exercise is considered to be dependent mainly on increases in heart rate and contractility. When ischemic conditions are induced during exercise, the contractility decreases and pump function is compensated through an increase in preload.13),23) An important effect of antianginal drug intervention during acute ischemia is reported to both size and profile of the P-V index, despite its apparent anti-ischemic effect. This result supports the conclusion that propranolol also achieves its antianginal effect by significantly suppressing myocardial contractility. The response curves of EDV with nifedipine and propranolol were similar in both size and profile. The EDV response curve of ISDN was similar to that of placebo in profile, but was not different in size from the other drugs. These findings indicate that ISDN does not alter the basic physiologic response to exercise in patients, but rather, resets baseline EDV at a more favorable level so that the changes during exercise are not so extreme, while other drugs are considered to have almost no direct effect on preload, and to show similar EDV levels based on other mechanisms.
The SVR response curve of nifedipine was similar to that of placebo in profile, but it was significantly differentiated from those of other drugs in size. This finding supports the conclusion that nifedipine acts directly on SVR and is considered to be a typical afterload reducing drug.7) The SVR response curve of propranolol was also similar to that of placebo in profile, but its profile was opposite to that of nifedipine (see Fig.5 ). Thus, propranolol increases SVR, although it acts directly on SVR too. ISDN is suggested to have no significant effect on SVR because there was no significant difference between ISDN and placebo in either size or profile of the SVR response curve.
Previously, precise evaluation of the effects of drugs on cardiac function during ischemia was very difficult. There are only a few reports comparing the hemodynamic effects of these 3 antianginal drugs during exercise.25), 26) Their results were consistent with ours by univariate ANOVA, however, the hemodynamic effects of the drugs were not fully differentiated from each other during exercise. Although PANOVA is the method of statistical analysis which is applied to analyzing the profiles of response curves, there has been only one paper which reported the usefulness of PANOVA in the assessment of hemodynamic changes during exereise. 19 We performed exercise RNA following administration of four regimens to obtain the response curves of important hemodynamic parameters.
We applied PANOVA to the analysis of these response curves and found that the differences in profile and/or size of the response curves could sufficiently demonstrate the characteristics of each drug.
In conclusion, with the aid of PANOVA, the changes in hemodynamic parameters during ischemia were evaluated in a manner that was highly effective in differentiating the characteristics of the effects of antianginal drugs.
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